Standard Life offloads more properties in Canada
Insurance group Standard Life has said that the recent sales of offices in Canada would bolster its bottom line this year, as it attempts to cut its exposure to property as an asset class.
Insurance group Standard Life has said that the recent sales of offices in Canada would bolster its bottom line this year, as it attempts to cut its exposure to property as an asset class.
Following on from the disposal of two properties last month, the company announced on Wednesday morning that it had sold a further two offices in Eastern and Central Canada.
The four sales will contribute to operating profit before tax for the year ending December 31st with the aggregate one-off contribution expected to be total around £140m.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company said in November that it had renegotiated a reinsurance agreement in Canada which helped to improve its risk profile.
"At Standard Life, our focus is on maximising shareholder value and driving more effective management of liabilities. Today we have announced transactions in Canada intended to achieve that purpose," said Chief Financial Officer Jackie Hunt.
"We have taken advantage of significant demand in the market for premier quality investment properties across Canada, while at the same time reducing exposure to property as an asset class.Excluding these transactions, our Canadian business continues to trade in line with expectations."
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
What the Employment Rights Bill means for your job
New workplace reforms are set to give employees new rights to benefits and flexible working
By Marc Shoffman Published
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published